A neurostimulation patch (102, 202, 302, 602, 702, 802, 1102) is affixed to a patient's skin (e.g., via a medical skin adhesive (118, 218, 330, 630, 730)) and provides stimulation energy for an implanted lead (104, 204, 808, 1104). The patch (102, 202, 302, 602, 702, 802, 1102) may be used for SCS trials or other applications where is it desirable to avoid implanting a stimulation device within a patient. Circuitry (108, 208, 312, 612, 712, 804) in the patch (102, 202, 302, 602, 702, 802, 1102) generates stimulation signals and couples these signals to the implanted lead (104, 204, 808, 1104). The signals may be coupled to the lead (104, 204, 808, 1104) via a direct physical connection or via a wireless connection. In some embodiments, the neurostimulation patch (102, 202, 302, 602, 702, 802, 1102) is configured in a manner that enables the patch (102, 202, 302, 602, 702, 802, 1102) to be placed immediately above the puncture site where an associated percutaneous lead (104, 204, 808, 1104) passes through a patient's skin, thereby protecting the puncture site and facilitating secure routing of the lead (104, 204, 808, 1104).
